- Home
- Publications
- Publication Search
- Publication Details
Title
Directly Acting Antivirals for COVID-19: Where Do We Stand?
Authors
Keywords
-
Journal
Frontiers in Microbiology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-05
DOI
10.3389/fmicb.2020.01857
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 Novel coronavirus: where we are and what we know
- (2020) Zhangkai J. Cheng et al. INFECTION
- Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China
- (2020) Zunyou Wu et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Coronavirus Disease 2019 and Influenza
- (2020) Edward Livingston et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore
- (2020) Barnaby Edward Young et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- First Case of 2019 Novel Coronavirus in the United States
- (2020) Michelle L. Holshue et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Coronavirus from Patients with Pneumonia in China, 2019
- (2020) Na Zhu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Umifenovir treatment is not associated with improved outcomes in patients with coronavirus disease 2019: a retrospective study
- (2020) N. Lian et al. CLINICAL MICROBIOLOGY AND INFECTION
- Factors associated with prolonged viral shedding and impact of Lopinavir/Ritonavir treatment in hospitalised non-critically ill patients with SARS-CoV-2 infection
- (2020) Dan Yan et al. EUROPEAN RESPIRATORY JOURNAL
- Involving antimicrobial stewardship programs in COVID-19 response efforts: All hands on deck
- (2020) Michael P. Stevens et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- Risk-adapted Treatment Strategy For COVID-19 Patients
- (2020) Changcheng Zheng et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Arbidol monotherapy is superior to lopinavir/ritonavir in treating COVID-19
- (2020) Zhen Zhu et al. JOURNAL OF INFECTION
- Arbidol combined with LPV/r versus LPV/r alone against Corona Virus Disease 2019: A retrospective cohort study
- (2020) Lisi Deng et al. JOURNAL OF INFECTION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
- (2020) Yeming Wang et al. LANCET
- Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
- (2020) Fei Zhou et al. LANCET
- The many estimates of the COVID-19 case fatality rate
- (2020) Dimple D Rajgor et al. LANCET INFECTIOUS DISEASES
- Arbidol/IFN-α2b Therapy for Patients With Corona Virus Disease 2019: A Retrospective Multicenter Cohort Study
- (2020) Ping Xu et al. MICROBES AND INFECTION
- Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
- (2020) Jason D. Goldman et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Compassionate Use of Remdesivir for Patients with Severe Covid-19
- (2020) Jonathan Grein et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical characteristics and therapeutic procedure for four cases with 2019 novel coronavirus pneumonia receiving combined Chinese and Western medicine treatment
- (2020) Zhenwei Wang et al. BioScience Trends
- Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
- (2020) Philippe Gautret et al. Travel Medicine and Infectious Disease
- Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
- (2020) Chaomin Wu et al. JAMA Internal Medicine
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- Effectiveness of Arbidol for COVID-19 Prevention in Health Professionals
- (2020) Chunguang Yang et al. Frontiers in Public Health
- Patients of COVID-19 may benefit from sustained Lopinavir-combined regimen and the increase of Eosinophil may predict the outcome of COVID-19 progression
- (2020) Fang Liu et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Lopinavir/ritonavir as a third agent in the antiviral regimen for SARS-CoV-2 infection
- (2020) Periklis Panagopoulos et al. JOURNAL OF CHEMOTHERAPY
- A study on clinical effect of Arbidol combined with adjuvant therapy on COVID‐19
- (2020) Wenyu Chen et al. JOURNAL OF MEDICAL VIROLOGY
- Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID‐19: A retrospective study in two designated hospitals in Anhui, China
- (2020) Yan Zuo et al. JOURNAL OF MEDICAL VIROLOGY
- Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status
- (2020) Spinello Antinori et al. PHARMACOLOGICAL RESEARCH
- Lopinavir-ritonavir versus hydroxychloroquine for viral clearance and clinical improvement in patients with mild to moderate coronavirus disease 2019
- (2020) Ji-Won Kim et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Baloxavir marboxil susceptibility of influenza viruses from the Asia-Pacific, 2012–2018
- (2019) Paulina Koszalka et al. ANTIVIRAL RESEARCH
- Pharmacist services in nursing home: A systematic review and meta‐analysis
- (2019) Shaun Wen Huey Lee et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
- (2018) Jan Haviernik et al. Viruses-Basel
- The Antiviral Drug Arbidol Inhibits Zika Virus
- (2018) Susan L. Fink et al. Scientific Reports
- Sample size calculation for a stepped wedge trial
- (2015) Gianluca Baio et al. Trials
- Arbidol as a broad-spectrum antiviral: An update
- (2014) Julie Blaising et al. ANTIVIRAL RESEARCH
- Azvudine, A Novel Nucleoside Reverse Transcriptase Inhibitor Showed Good Drug Combination Features and Better Inhibition on Drug-Resistant Strains than Lamivudine In Vitro
- (2014) Rui-Rui Wang et al. PLoS One
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now